Trastuzumab Deruxtecan Secures EU Approval for Residual HER2-Positive Early Breast Cancer Following DESTINY-Breast05 Survival-Free Disease Benefit
FASCO 2027: Recognizing Dedication to Oncology
ASCO 2026.3.4 Living Guideline: Lorlatinib Takes Priority in First-Line ALK-Positive NSCLC After Landmark Seven-Year CROWN Results
Jeff Dunn on Cancer Equity: The Powerful Message Behind “Poverty Is a Carcinogen”
Carla Ferrell and Sista Strut 2026: Breast Cancer Awareness Mission
Top Gastroesophageal Cancer Updates From ESMO 2026
A New Chance to Prevent Recurrence: EU Approves Trastuzumab Deruxtecan for HER2-Positive Early Breast Cancer
Arun Azad: New TALAPRO-2 Data Highlight the Prognostic Value of ctDNA and CTCs in Prostate Cancer
The AACR–NCI–EORTC International Conference on Molecular Targets and Cancer Therapeutics 2027 will take place on October 26–30, 2027, at the Sheraton Grand Chicago Riverwalk in Chicago, Illinois, United States. The international meeting is jointly organized by the American Association for Cancer Research (AACR), National Cancer Institute (NCI), and European Organisation for Research and Treatment of […]
